Liquidia Corporation Common Stock vs Schwab US Dividend Equity ETF — how do they compare? Liquidia Corporation Common Stock trades at $32.42 (market cap $3.04B), while Schwab US Dividend Equity ETF trades at $34.2 (market cap $111.61B). The key difference: Schwab US Dividend Equity ETF is far larger — about 36.7× Liquidia Corporation Common Stock's market cap, and Schwab US Dividend Equity ETF is trading nearer its 52-week high, Liquidia Corporation Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Liquidia Corporation Common Stock for 0 Days and Schwab US Dividend Equity ETF for 64 Days on average.
| LQDA | SCHD | |
|---|---|---|
Market Cap | $3.04B | $111.61B |
Volume | 21,111,778 | 25,598,052 |
Sector | Health | Broad Market / Factor |
52-Week High | $91.03 | $35.21 |
52-Week Low | $22.02 | $26.44 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $2.94B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SCHD trades at $33.37, up 0.33% on the day, with a bullish technical signal driven by moving averages. The ETF's dividend-focused strategy is highlighted in recent news, with articles noting its outperformance against the S&P 500 in 2026 and its appeal for income investors. Key support and resistance cluster around $33, while RSI levels show mixed momentum signals.
Outlook remains positive for dividend growth and defensive positioning, but risks include interest rate sensitivity and potential missed gains from strict stock selection rules. Investors benefit from lower fees and rising payouts, though macroeconomic shifts could pressure yields.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Liquidia Corporation is a biopharmaceutical company that develops therapies for rare cardiopulmonary diseases, including YUTREPIA, an inhaled treprostinil powder for pulmonary hypertension built on its PRINT technology.
Read more on LQDA →SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →